sacubitril 24 MG / valsartan 26 MG [Entresto]
- RxCUI
- 1656342
- RxNorm name
- sacubitril 24 MG / valsartan 26 MG [Entresto]
- Term type
- SBDC
- Status
- Active
- Updated
- 2026-10-29 07:11:00
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 082015
- Active start
- 082015
- Multiple ingredient
- YES
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| 24 MG / 1 EACH | sacubitril | ||
| 26 MG / 1 EACH | valsartan |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| sacubitril | 1656328 |
| valsartan | 69749 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | sacubitril 24 MG / valsartan 26 MG [Entresto] | 1 | NAMES |
| RxNorm Name | sacubitril 24 MG / valsartan 26 MG [Entresto] | 1 | NAMES |
| TTY | SBDC | 1 | ATTRIBUTES |
| RxCUI | 1656342 | 1 | CODES |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | C09DX | Angiotensin II receptor blockers (ARBs), other combinations | ATC1-4 | sacubitril / valsartan | |
| ATC | C09CA | Angiotensin II receptor blockers (ARBs), plain | ATC1-4 | valsartan | |
| FDASPL | N0000175561 | Angiotensin 2 Receptor Blocker | EPC | has_epc | valsartan |
| FDASPL | N0000000070 | Angiotensin 2 Receptor Antagonists | MOA | has_moa | valsartan |
| MEDRT | D000613 | Aminobutyrates | CHEM | has_ingredient | sacubitril |
| MEDRT | D001713 | Biphenyl Compounds | CHEM | has_ingredient | sacubitril |
| MEDRT | D000068756 | Valsartan | CHEM | has_ingredient | valsartan |
| MEDRT | D003928 | Diabetic Nephropathies | DISEASE | may_treat | valsartan |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | sacubitril |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | valsartan |
| MEDRT | D006333 | Heart Failure | DISEASE | may_prevent | sacubitril |
| MEDRT | D006333 | Heart Failure | DISEASE | may_treat | valsartan |
| MEDRT | D006929 | Hyperaldosteronism | DISEASE | ci_with | valsartan |
| MEDRT | D006973 | Hypertension | DISEASE | may_treat | valsartan |
| MEDRT | D007022 | Hypotension | DISEASE | ci_with | valsartan |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | valsartan |
| MEDRT | D018487 | Ventricular Dysfunction, Left | DISEASE | may_treat | valsartan |
| MEDRT | N0000000070 | Angiotensin 2 Receptor Antagonists | MOA | has_moa | valsartan |
| MEDRT | N0000191727 | Neprilysin Inhibitors | MOA | has_moa | sacubitril |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | has_pe | valsartan |
| MEDRT | N0000008669 | Decreased Intravascular Volume | PE | has_pe | valsartan |
| MEDRT | N0000008731 | Decreased Mineralocorticoid Secretion | PE | has_pe | valsartan |
| MEDRT | N0000008859 | Decreased Renal K+ Excretion | PE | has_pe | valsartan |
| MEDRT | N0000009553 | Increased Renal Na+ Excretion | PE | has_pe | valsartan |
| MEDRT | N0000009825 | Renal Arterial Vasoconstriction | PE | ci_pe | valsartan |
| MEDRT | N0000009826 | Renal Arterial Vasodilation | PE | has_pe | valsartan |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |